The Metabolic Genetic Testing Market to witness the mobile health-oriented renaissance

Print Friendly, PDF & Email

The Metabolic Genetic Testing Market is likely to grow on a robust note in the next decade. The next decade would be seeing the integration of telehealth services with the physical ones that exist at the moment. Urgent care and primary care are bound to be accessed through virtual visits, along with improvement in collaboration with the clinics, dialysis centres, long-term care facilities, and mental health services. This shifting is to be witnessed in the healthcare vertical shortly.

According to the latest research by Persistence Market Research, the metabolic genetic testing market is set to witness positive growth of CAGR 8% during 2021-2031. Metabolic genetic disorders are caused due to either absence of any gene or presence of inactive gene leading to enzyme deficiency. These are also known as inborn errors of metabolism.

Currently there are thousands of inherited metabolic disorders. Some of them include lysosomal storage disorders, mitochondrial disorders, metal metabolism disorders, sun sensitivity, thyroid disease etc.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32864

The metabolic genetic testing market is majorly driven by advancements in DNA sequencing techniques, increasing research in human genetics and awareness about the testing techniques. These testing method provides an accurate course of treatment and specific investigations.

The market is majorly driven by increase in the prevalence of genetic metabolic disorders, change in lifestyle, technological advancements in the screening techniques, awareness about genetic testing and increasing research and development. Various technological advancements are happening in DNA sequencing.

Next-generation sequencing is the new method that is currently used for DNA sequencing. The change in lifestyle during the previous years have led to increase in the risk of genetic metabolic diseases. Another driver is the prevalence of various metabolic genetic disorders.

According to report, it is estimated that more than one third of population in US have metabolic risk. This increase in the prevalence therefore acts as a driven for metabolic genetic testing market. An increase in the awareness about the genetic testing for the disorder and R & D investment by the companies for developing new techniques.

For instance, in 2019, Centogene N.V launched CentoMetabolic, a panel for detection of rare metabolic disease. These factors are expected to increase demand for metabolic genetic testing during the forecast period.

COVID-19 had an impact on the metabolic genetic testing market. Since only the essential treatments were allowed during the pandemic, the screening and many early signs of metabolic genetic disorders went undetected.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32864

However, this pandemic has allowed researchers to come up with new techniques for metabolic genetic testing. Due to change in lifestyle, the risk of metabolic diseases have risen. Therefore, having a positive impact on the market.

Some of the leading manufacturers of metabolic genetic testing include,

  • Centogene N.V.
  • MedGenome
  • Blueprint Genetics Oy
  • Invitae Corporation
  • Quest Diagnostics
  • Orig3n
  • Bionano Genomics
  • Devyser

North America with countries like US and Canada re dominating the metabolic genetic market. These region have major manufacturing companies and increase in the investments by them for new techniques are driving the market. Also, the governmental initiatives for genetic testing and increase in funding act as a driver for the market.

In addition to this, the prevalence rate of genetic renal disorder is high. Another region that is expected to dominate the market is Asia followed by Europe. This is due to presence of some player like MedGenome in this region and increase in life science research is expected to drive the market.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/32864

Key Segments:

By Technique

  • Next generation sequencing
  • Multiplex Ligation-dependent Probe Amplification (MLPA)
  • Amniocentesis

By Indication

  • Amino acid metabolism disorders
  • Carbohydrate metabolism disorders
  • Fatty acid metabolism disorders
  • Purine and pyrimidine metabolism disorders

By End-user

  • Hospitals
  • Specialty clinics
  • Research institutes
  • Diagnostics laboratories

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Click here for original article.